© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Agreement to Acquire Boehringer
Posted 7th October 2016

Agreement to Acquire Boehringer

Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Agreement to Acquire Boehringer
Image

Eight new product lines and a fully integrated manufacturing and R&D site to transfer to Elanco, adding to its growing companion animal business; subject to FTC approval and closing of BI/Sanofi asset swap

Today Elanco U.S., Inc., a subsidiary of Eli Lilly and Company, announced an agreement to acquire Boehringer Ingelheim Vetmedica, Inc.’s (BIVI) U.S. feline, canine and rabies vaccines portfolio – as well as a fully integrated manufacturing and R&D site – for $885 million, including the estimated cost of acquired inventory. The deal will diversify Elanco’s U.S. companion animal portfolio by complementing its offerings for dogs and cats.

Joining Elanco’s U.S. portfolio – which currently includes parasiticides, pain and dermatology medicines – will be routinely administered vaccines for bordetella, Lyme disease, rabies and parvovirus, among others. Also included in the agreement are several pipeline assets.

The Fort Dodge, Iowa-based facility brings capacity to manufacture the acquired products as well as R&D and testing capabilities, including an on-site veterinary research center and lab space.

“We understand the unique bond that owners share with pets and are committed to helping those pets live longer, healthier lives,” said Jeff Simmons, president, Elanco Animal Health. “With a growing portfolio addressing both prevention and treatment of disease, Elanco can partner with veterinarians and pet caregivers to do just that.”

The acquisition is anticipated to close by early 2017, subject to approval by the Federal Trade Commission and also subject to antitrust approval and closing of Boehringer Ingelheim’s asset swap transaction with Sanofi.

The sale of BIVI’s U.S. pet vaccines business and Fort Dodge manufacturing site is a required step toward the acquisition of Merial by Boehringer Ingelheim.

The current vaccine portfolio to be acquired has experienced revenue growth over the past three years, and Lilly expects the acquisition to be accretive to GAAP earnings in 2019 and to non-GAAP earnings in 2018.

John C. Lechleiter, Ph.D., Lilly’s chairman, president and chief executive officer, said that the planned acquisition of BIVI’s U.S. feline, canine and rabies vaccines portfolio reaffirms Lilly’s confidence in Elanco’s growth potential.

“As a result of the acquisition, Elanco will bring greater value to customers by providing a suite of options for preventing common diseases in companion animals,” said Lechleiter. “Coupled with our robust food animal portfolio, this addition further strengthens Elanco’s position in the global animal health business.”

Jefferies LLC is acting as the exclusive financial advisor and Paul Hastings LLP and Paul, Weiss, Rifkind, Wharton & Garrison LLP are acting as legal advisors to Elanco and Lilly in this transaction.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Navigating the Path to Criminal Rehabilitation: A Comprehensive Guide for Entry to Canada
News
27/11/2023Navigating the Path to Criminal Rehabilitation: A Comprehensive Guide for Entry to Canada

Navigating the Path to Criminal Rehabilitation: A Comprehensive Guide for Entry to Canada Embarking on the journey to enter Canada after a criminal conviction can be a challenging process. However, with the right approach and understanding of the steps involve

Read Full PostRead - Eye Icon
Maximizing ROI: How SharePoint Consultants Drive Business Value
News
19/02/2024Maximizing ROI: How SharePoint Consultants Drive Business Value

SharePoint, developed by Microsoft, is a powerful platform designed to facilitate collaboration, document management, and information sharing within organizations. While the platform offers a plethora of features and capabilities, maximizing its return on inve

Read Full PostRead - Eye Icon
Meeting the Highest Standards of Competence and Professionalism
Leadership
30/08/2019Meeting the Highest Standards of Competence and Professionalism

Boccadutri is an Italian law firm that specialises in assisting international clients with legal matters in Italy and Italian clients abroad.

Read Full PostRead - Eye Icon
Eurozone’s GDP Boost Should Ease Negotiations
Finance
16/02/2015Eurozone’s GDP Boost Should Ease Negotiations

GDP in the Eurozone grew by 0.3% quarter-on-quarter during Q4 2014, faster than expected.

Read Full PostRead - Eye Icon
Hospice Revenue Integrity: Eliminating 835 ERA Posting Errors That Distort A/R and Cash Forecasting
Technology
29/01/2026Hospice Revenue Integrity: Eliminating 835 ERA Posting Errors That Distort A/R and Cash Forecasting

Managing hospice billing can feel like trying to solve a puzzle where the pieces keep changing. Accounts receivable reports often look off, and cash forecasts never seem to match reality. Advanced RevCycle can help uncover the root of these problems by address

Read Full PostRead - Eye Icon
How a Full HSE policy for a Growing Business Positively Impacts Employee Performance
News
21/09/2023How a Full HSE policy for a Growing Business Positively Impacts Employee Performance

If you’re growing a business, you likely have a long “to-do” list. Let’s look at why having a full Health, Safety and Environment (HSE) policy should be right at the top. Why do you need an HSE policy in place as your business grows, and how can it imp

Read Full PostRead - Eye Icon
Most Innovative Virtual Learning Businesswoman 2022: Christine Janssen, PhD
News
12/07/2022Most Innovative Virtual Learning Businesswoman 2022: Christine Janssen, PhD

Acquisition International’s Influential Businesswoman Awards 2022 celebrates the brightest and best that organisations around the world have to offer. Few fit the bill more successfully than Christine Janssen. She has built a business that is perfectly suite

Read Full PostRead - Eye Icon
Trigon Advise on Public Consulting Group’s Acquisition of Librus from Oresa Ventures
M&A
27/08/2015Trigon Advise on Public Consulting Group’s Acquisition of Librus from Oresa Ventures

Trigon Advise on Public Consulting Group's Acquisition of Librus from Oresa Ventures

Read Full PostRead - Eye Icon
Augmenting Lives Through Artificial Intelligence
Innovation
21/01/2020Augmenting Lives Through Artificial Intelligence

Technology has proven to be a demonstrably powerful tool in helping people living with disabilities to live truly autonomous lives. In the world today, rapid advancements in areas such as artificial intelligence and machine learning have meant that empowering



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow